Xortx Therapeutics Stock Market Value
| XRTX Stock | USD 1.27 0.06 4.96% |
| Symbol | XORTX |
XORTX Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XORTX Therapeutics. If investors know XORTX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XORTX Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.12 | Return On Assets (0.33) | Return On Equity (0.29) |
The market value of XORTX Therapeutics is measured differently than its book value, which is the value of XORTX that is recorded on the company's balance sheet. Investors also form their own opinion of XORTX Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is XORTX Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XORTX Therapeutics' market value can be influenced by many factors that don't directly affect XORTX Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XORTX Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if XORTX Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XORTX Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
XORTX Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to XORTX Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of XORTX Therapeutics.
| 12/07/2023 |
| 12/01/2024 |
If you would invest 0.00 in XORTX Therapeutics on December 7, 2023 and sell it all today you would earn a total of 0.00 from holding XORTX Therapeutics or generate 0.0% return on investment in XORTX Therapeutics over 360 days. XORTX Therapeutics is related to or competes with Context Therapeutics, Neurosense Therapeutics, Quoin Pharmaceuticals, and Ensysce Biosciences. XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to ... More
XORTX Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure XORTX Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess XORTX Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.87 | |||
| Information Ratio | 0.0569 | |||
| Maximum Drawdown | 157.0 | |||
| Value At Risk | (11.11) | |||
| Potential Upside | 16.04 |
XORTX Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for XORTX Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as XORTX Therapeutics' standard deviation. In reality, there are many statistical measures that can use XORTX Therapeutics historical prices to predict the future XORTX Therapeutics' volatility.| Risk Adjusted Performance | 0.0588 | |||
| Jensen Alpha | 0.8881 | |||
| Total Risk Alpha | (1.88) | |||
| Sortino Ratio | 0.1317 | |||
| Treynor Ratio | 0.5373 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of XORTX Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
XORTX Therapeutics Backtested Returns
XORTX Therapeutics shows Sharpe Ratio of -0.091, which attests that the company had a -0.091% return per unit of risk over the last 3 months. XORTX Therapeutics exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out XORTX Therapeutics' Mean Deviation of 7.45, downside deviation of 7.87, and Market Risk Adjusted Performance of 0.5473 to validate the risk estimate we provide. The firm maintains a market beta of 2.17, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, XORTX Therapeutics will likely underperform. At this point, XORTX Therapeutics has a negative expected return of -0.63%. Please make sure to check out XORTX Therapeutics' value at risk, kurtosis, market facilitation index, as well as the relationship between the semi variance and rate of daily change , to decide if XORTX Therapeutics performance from the past will be repeated at some future point.
Auto-correlation | 0.18 |
Very weak predictability
XORTX Therapeutics has very weak predictability. Overlapping area represents the amount of predictability between XORTX Therapeutics time series from 7th of December 2023 to 4th of June 2024 and 4th of June 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of XORTX Therapeutics price movement. The serial correlation of 0.18 indicates that over 18.0% of current XORTX Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | -0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.11 |
XORTX Therapeutics lagged returns against current returns
Autocorrelation, which is XORTX Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting XORTX Therapeutics' stock expected returns. We can calculate the autocorrelation of XORTX Therapeutics returns to help us make a trade decision. For example, suppose you find that XORTX Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
XORTX Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If XORTX Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if XORTX Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in XORTX Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
XORTX Therapeutics Lagged Returns
When evaluating XORTX Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of XORTX Therapeutics stock have on its future price. XORTX Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, XORTX Therapeutics autocorrelation shows the relationship between XORTX Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in XORTX Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.